chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Lost taste one hour after 2nd Covid vaccine was administered; experiencing cold like symptoms; This is a spontaneous report received from a non-contactable consumer (patient). A male patient in his late 40s received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot Number: not reported), via an unspecified route of administration on 02Apr2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history included seasonal allergies (taking multiple antihistamines) from an unknown date and unknown if ongoing. The concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot Number: not reported) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunization. On an unspecified date, the patient lost taste one hour after 2nd Covid vaccine was administered and experiencing cold like symptoms. It was reported that taste has returned but was still experiencing cold like symptoms. The patient underwent lab tests and procedures which included rapid Covid test was negative on an unspecified date. Outcome of the events lost taste one hour after 2nd Covid vaccine was administered was recovered on an unspecified date and still experiencing cold like symptoms was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained
Pain at injection, swelling and numbness in hand following shot.  11/24/2009 PCP records for 10/30/2009, Dx allergic reaction  patient with c/o's lt arm swelling and pain. Has normal ROM lt arm, good grip strength. given RX for steroids and Ultram for pain. 12/2/2009 MR for admission 11/2-11/5/2009 for progressive LUE swelling and pain, thrombectomy done after Doppler study revealed extensive DVT,LUE, DC'd on ASA and Coumadin. Tx IV ABX 12/2/2009 ED records for 11/12/2009, patient presents with c/o's maculopapular rash on back, chest, arms and lt leg, rx'd Benadryl, told to hold ASA 12/28/2009 ED records for 11/14/2009, Dx pleurisy  patient presents with c/o's chest pain and SOB.  TX Telemetry, IVF
Pt came to vaccine clinic requesting J&J vaccine. Reviewed checklist that was completed by pt in clinic, on said checklist pt checked NO in response to "Have you ever received a dose of COVID-19 vaccine?" Pt's name clicked in system, notice flashed in red that pt not due for vaccine of J&J due to inappropriate at this time. ?Pt. Questioned by me, states this is first vaccine. ?Pt states she gets vasovagal response and fainting feeling to needles and shots in the past, pt placed into blue easy chair in the clinic to prevent injury in the event pt has vasovagal response as described. ?J&J vaccine administered with second RN in attendance. ?Within 5 minutes pt became faint, asked to be placed on floor - then placed on stretcher - Vitals B/P 113/75, heart rate 86, O2 Sat 97 at 5:05. ?Public response called at 5:03 PM, evaluated by ED team and found to be stable. ?Pt. Questioned about receiving a prior covid vaccine, pt first stated today's vaccine was her first; upon further questioning pt states she received a pfizer vaccine months ago but could not remember when. ?Pt. States she took the vaccine today because she was afraid that she would have to restart pfizer vaccine series again and would not have it in time to get into school classes, so she decided to get J&J vaccine today. Pt advised by Staff on possible side effects of vaccine and to go to ED if experiences same. ?Pt advised Staff will call her via phone tomorrow 8-12-21 and 8-13-221 to check on her and how she is feeling. ?Pt agreeable to same. 5:10 B/P 110/75, heart rate 89m O2 Sat 98. 5:15 B/P 108/72, heart rate 89. ?O2 Sat 98 Pt discharged via WC with friend who will drive her home.
Stabbing pains in throat started within a week of vaccine.  Turned into excruciating pain in Feb 2023.  Now diagnosed with Hypoglossal neuralgia. Possible underlying causes of MS, Lou Gherig's, brain aneurysm and brain tumor have all been ruled out.
Pt feels tired, no energy. Back and muscles ache. States she feels "fragile". Sinus congestion.
Swelling lips, tongue swelling, asthma started  to tighten chest,  itchy hands, feet, umber arms, around the waist,  treated with over the counter antihistamines for two weeks.  Very sensitive to things I am allergic too.  Hope it goes away.
After injecting 0.5ml of air into the multi-dose vial of vaccine, leakage of vaccine was observed coming from between the metal cap and rubber stopper. The leakage was described to me as looking like the size of a tear drop. On inspection of the vials, it was noted that the metal cap was not tight and we were able to spin the cap around the vial. I called Novartis on 9/22/11 to report this as I had concerns about the integrity of the vial due to the loose metal cap. NDC 66521-114-10 lot 1100901 exp 5/2012. I checked vials that had not been opened yet and they also had loose metal tops. Novartis did not seem overly concerned and indicated that they would get back to me. I have not heard from them as of today (9/26/11). At issue for our hospital is that we have already dispensed >/= to 450 doses of vaccine.
Developed a raised, red, itchy reaction one week after injection; had a similar reaction the day of and following the injection, but it had gone away after 3 days
Pt passed out & shaking (possible seizure) shortly after injection.  911 called. Pt conscious after 1-2 minutes.  Declined transport to ER.  Monitored by RN and pharmacist for 45 min.  Pt's husband drove her home when status returned to normal
Pt seen at 11:00am for 2 months well visit with immunization. Pt given Boostrix Tdap in error instead of Pediarix (Dtap, IPV, Hib B). No adverse symptoms noticed. No treatment ordered. Called at 5:00 pm talk to mom pt has 102 temp Tylenol given. To re vaccinate with Dtap in 1 week, will check on pt in AM.
This spontaneous report was received from a nurse referring to multiple unspecified patients of unknown age and gender. Pertinent medical histories, drug reactions or allergies and concomitant therapies were not reported. On unspecified dates after 24-MAR-2015, the patients were vaccinated with improperly stored doses of M-M-R II (lot # J016232 with an expiry date 19-DEC-2015, doses, frequencies and route were not reported. No adverse effects were reported. It was reported that vaccines were not discontinued. There was no product quality complaint (PQC) involved. This is one of the several reports received from the same reporter. Additional information has been requested.
w/in 1 hr of DTP pt was lethargic, h/a, no appetite, slept alot, high temp; evening of 10JAN92 pt was taken ot ER & treated for the same; s&s lasted 3 days; pt was not hospitalized;
08/28/22 presents to Birth Center Triage for "contractions". PMHx of "no past medical history on file"
dizziness; Could not lift head off pillow; very sore arm/arm pain; Headache; Vomited; fever; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), MOBILITY DECREASED (Could not lift head off pillow), PAIN IN EXTREMITY (very sore arm/arm pain), HEADACHE (Headache) and VOMITING (Vomited) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma, Bronchiectasis, Allergy to antibiotic (allergy to vancomycin) and Allergy to plants (allergy to Echinacea).    On 11-Jan-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced DIZZINESS (dizziness), MOBILITY DECREASED (Could not lift head off pillow), PAIN IN EXTREMITY (very sore arm/arm pain), HEADACHE (Headache), VOMITING (Vomited), PYREXIA (fever) and FATIGUE (Tiredness). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 14-Jan-2021, DIZZINESS (dizziness), MOBILITY DECREASED (Could not lift head off pillow), PAIN IN EXTREMITY (very sore arm/arm pain), HEADACHE (Headache), VOMITING (Vomited), PYREXIA (fever) and FATIGUE (Tiredness) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Jan-2021, Body temperature: 100 (High) 100.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications reported. The patient slept for 2 days, rested and self hydrated for treatment.   This case was linked to MOD-2021-323632, MOD-2021-310473 (Patient Link).
Patient received Moderna Vaccine but is under the age of 18 years.  Patient also received a second dose on 04-26-2021 AT 05:44 PM Lot Number 039B21A
I was getting headaches and coughing a lot at first. It got really bad and then I went to the doctor because my coughing was getting so bad. I contacted my doctor and was prescribed prednisone and ROBITUSSIN. I am feeling better now, but still dealing with the cough, it is not as bad though.
Polymyalgia Rheumatica sudden onset: Blood Pressure and HRT significant decline necessitating pace maker and new heart medications.  Under treatment for heart, BP still not regulated. Using Prednisone for PMR which has involved entire body,  Long term care not yet decided.
patient got Guillian-Barre / patient died from it/ passed away; wound up in a wheel chair suffered; Initial information received on 03-Dec-2020 regarding an unsolicited valid serious case from a non-health care professional (Patient's Friend) via social media.  This case involved female patient of unknown age who developed Guillian-Barre/ died from it /passed away (Guillain-Barre syndrome) and wound up in a wheel chair (wheelchair user) , after receiving INFLUENZA VACCINE.  The patient's past vaccinations included flu shot.  Medical history, medical treatment(s), concomitant medication(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiration date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed serious events of Guillian-Barre/ died from it/ passed away (Guillain-Barre syndrome) and wound up in a wheel chair (wheelchair user) unknown latency, following the vaccination. These events were assessed as medically significant and were leading to disability. It was reported that patient suffered for about 4 years.  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  The outcome was fatal for the event Guillain-Barre syndrome and died on an unknown date. It was unknown if an autopsy was done. The cause of death was reported as Guillain-Barre syndrome.  Information on the batch number to be requested for this case; Sender's Comments: This poorly documented social media involves a female patient of unknown age who presented Guillain-Barre syndrome, wounded up in a wheel chair and died after vaccination with an INFLUENZA VACCINE. Time to onset is unknown. The cause of death was unspecified. Moreover, additional information regarding their relevant medical history, health condition at time of vaccination and Laboratory tests, autopsy results is needed for complete assessment of the case. Based upon the reported information, the role of the vaccine cannot be assessed.; Reported Cause(s) of Death: Guillain Barre syndrome
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Sep2022 as dose 4 (booster), single (Lot number: GH9694) at the age of 35 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 12Mar2021 as dose 1, single (Lot number: EN6208), in left arm, on 31Mar2021 as dose 2, single (Lot number: ER8737), in right arm and on 29Sep2021 as dose 3 (booster), single (Lot number: FF8839), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "obese" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken (Paxlovid) as a result of vaccination failure, covid-19.
This is a spontaneous report from a contactable consumer (Pfizer employee and patient mother).  A 17-year-old male patient received TRUMENBA at 0.5 ml single and MENACTRA at 1 DF single, both on 19Aug2016 at 15:30, in arm, for immunisation. No other vaccine was given on the same day or within 4 weeks. Medical history none. There were no concomitant medications. The patient experienced high fever on 20Aug2016 with outcome of recovered in Aug2016, fatigue in Aug2016 with outcome of recovered in Aug2016, diarrhea in 21Aug2016 with outcome of recovered on 25Aug2016, chills on 20Aug2016 with outcome of recovered in Aug2016. Therapeutic measures were taken as a result of high fever and chills and included TYLENOL and ADVIL. The patient was treated at home. The patient visited the doctor who said that fever, chills and fatigue were probably associated with the vaccine (unspecified), the diarrhoea several days after may not be go away and it was related to Trumenba, not the Menactra vaccine. Follow-up (27Oct2016): New information received from the same contactable consumer includes: reaction data.
This spontaneous report as received from a physician refers to a 15 year old female patient. On 10-NOV-2012, the patient was vaccinated with the first dose of GARDASIL (lot # and dose not reported). On 07-DEC-2012, the patient was vaccinated with the second dose of GARDASIL (Subcutaneous injection) (lot # and dose not reported). No adverse effects were reported. Additional information is not expected.
The patient developed numbness in the toes of the right foot.  Highly unlikely that this has anything to do with the vaccine.
Patient states that she has had shoulder pain ever since she received her vaccine. Has not sought treatment thus far.
Rash on face and arms 8/21/15 comes and goes-no medication.
Information has been received from a health professional concerning a 5 year old male who on 28Dec99 was vaccinated SC with a 0.5ml dose of varicella virus vaccine live. There was no concomitant medication. On 13Apr04 the pt experienced 8-10 lesions on the trunk and was seen in the office. No treatment was required. No product quality complaint was involved. Additional information has been requested.
Small staring seizures, severe headaches, severe fatigue, severe muscle pain and weakness, numbness of the legs, loss of appetite, tremors, sleeping 15 to 20 hours a day.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Nurse) from product quality group. The reporter is the patient.  A 66-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Dec2020 as dose 1, single (Lot number: EJ1685), on 13Jan2021 as dose 2, single (Lot number: EJ1686), on 12Oct2021 as dose 3 (booster), single (Lot number: FE3590) and on 24Jul2022 at 11:00 as dose 4 (booster), single (Lot number: FP7139) at the age of 66 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The patient had no known allergies. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of vaccination failure, covid-19. The patient received Paxlovid from 26Jul2022 to 27Jul2022 for the treatment of COVID-19.; Sender's Comments: Based on known drug safety profile and temporal association, there is reasonable possibility of causal association reported between the events and the suspect drug BNT162B2
Nurse gave pediatric dose pfizer. Patient notified that she needed to come back in for adult booster dose of pfizer.
This spontaneous report was received from a nurse, concerning a 42 year old male patient. Medical history and concurrent conditions were not reported. On 16-MAY-2014, the patient was vaccinated with a dose M-M-R II (strength was not reported) lot # H009781, expiration date reported as 15-MAY-2014, 0.5 ml, subcutaneous route. Co-suspect and concomitant therapies were not reported. The nurse reported that on 16-MAY-2014, patient received an expired dose of M-M-R II. No adverse effect was reported. Additional information has been requested.
Severe Headache, muscle pain (all over body), chills, shaking, fever, weakness
This spontaneous report as received from a Licensed Practical Nurse regarding a 13 year old female patient. There was no information about concurrent condition and historical medication. On an unknown 2014 the patient completed her GARDASIL series. No concomitant medication was reported. On an unknown date the patient experienced headaches, tiredness, joint and muscle pain, and dizziness. Treatment was given for the event. Reporter did not know if adverse events occurred after each shot, or after completing the series. Patient visited specialist office to seek medical attention. No PQC (product quality complaint). It was reported that the therapy with GARDASIL was not discontinued. The outcome of headaches, tiredness, joint and muscle pain, and dizziness was unknown. Causality was unknown. Additional information has been requested.
Pt received vaccines 6/27/12 - found dead in crib (prone) next morning.
EXPERIENCED A SENSE OF NUMBNESS IN LEFT ARM AND HAND,ALSO A VISABLE PULSATING PULSE NOTICABLE IN LEFT WRIST.THE NUMBNESS AS GONE AWAY,BUT I CAN STILL SEE MY PULSE BEATING IN MY WRIST.
This spontaneous report as received from a medical assistant regarding a patient of unknown age and gender. Information on the concurrent condition, medical history and pertinent drug allergies of the patient were not reported. On 27-OCT-2015 the patient was vaccinated with improperly stored RECOMBIVAX HB (lot # L004754, expiry date-10-NOV-2016) (dose #, route, dose units and anatomical location were not specified). Concomitant medication was not reported. No adverse events were reported. There were no Product Quality Complaint (PQC) involved. This is one of several reports received from same reporter. Additional information has been requested.
Extreme muscle pain and weakness, cranial hypertension, vomiting.  Symptoms lasted roughly 24 hours, cranial hypertension resolved once vomiting subsided long enough to take pain medication.
Patient received the Covid vaccine on 5-13-21.  She had seen her PCP and did not tell him that she received it.  On 5-19-21 she received the Pneumovax and  2 days later she had extreme fatigue, body aches, weakness, fever, ear and throat pain.
Severe pain in the (L) Shoulder Joint with reddening and pus exodus material. Reduced ROM in (L) Shoulder. Symptoms began within 8 hours of administration and continue now 5 days post injection. Injection site is still raw/red with pus still exiting the injection site. First medical appointment with patient provider is scheduled for 14 December 2018 at 1600.
Nausea and vomiting at 05:00 and massive headache until 1600
developed redness and swelling at injection site 6 days after vaccination.   Mild itching at site, denies pain at site of injection after initial discomfort on day of injection that resolved.   Mild axillary discomfort noted on side of injection, physical exam not performed as this interview was conducted over telephone, patient does not report axillary swelling or palpable lymphadenopathy
PATIENT REPORTED  FEELING TINGLY AND "FUNNY". PATIENT WAS FLUSHED ON HER FACE AS WELL AT THE END OF THE 15 MINUTE OBSERVATION TIME. ADVISED PATIENT TO CONTINUE TO WAIT. PATIENT CONTINUED TO FEEL "STRANGE" AND PHARMACY STAFF PROVIDED HER WITH SOME COLD WATER.  PHARMACIST ASKED IF SHE WAS HAVING ANY TROUBLE BREATHING AND PATIENT RESPONDED NEGATIVE. PHARMACY STAFF ALSO CHECKED HER BP AND IT WAS AT 166/88. EMSA WAS NOTIFIED WHEN PATIENT'S SYMPTOMS HAD NOT CHANGED AND ARRIVED AT 10:50. PATIENT WAS TAKEN BY EMSA TO ED.
Administered with vaccine that has been refrozen; A spontaneous report was received from a nurse concerning a 42-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and was administered with vaccine that has been refrozen.   The patient's medical history was not provided. No relevant concomitant medications were reported.   On 28 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot: 025J20-2A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.  On 31 Dec 2020, the nurse reported she had been storing the mRNA-1273 vaccines at -20 degrees Celsius but discovered that prior to the vaccine administration facility receiving the vaccines on 24 Dec 2020, they had been stored at 38.2 degrees Fahrenheit at another facility. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the event, administered with vaccine that has been refrozen, was considered resolved on 28 Dec 2020.; Reporter's Comments: This report refers to a case of Product storage error for mRNA-1273. There were no reported AEs associated with this case of product storage error.
Pt presented to the office on 9/18/06 with hx of rash x 1 day. Febrile, over 300 vesicles scattered throughout torso, extremities and face. TX Aveeno bath, Benadryl Oral, and calamine. Tylenol PRN fever. No ASA. Isolate, Return visit PRN.
Approximately 6 hours after my  Shingles shot was administered, my muscles and joints started to ache on top of feeling exhausted.  I took 2 Kirtland brand ibuprofens (500mg) and the symptoms subsided temporarily.  I went to bed around 10 pm but I was awakened a couple of hours later with extreme body ache, headache, and shiver.  I felt warm but no fever.    Exhaustion and muscle ache became worst throughout the night.  I got up lightheaded around 6 am and took another 2 ibuprofens.  A few hours later most symptoms subsided.  Throughout the rest of the day, I felt tired but not incapacitated.   By the following day, I was back to normal.
pt recv vax & devel pruritic red, welt-like rash & urticaria on upper legs, thighs, arms & abd on 23AUG94; dx urticaria secondary to hep B vax & the pt was treated w/DPH & Atarax;
Moderna COVID-19 Vaccine EUA - painful armpit in left arm where shot was given, started on Tuesday 4/27 upon waking at 6 AM and continues through today 4/29/21 at 9PM and has not yet resolved.
Upon waking on Tuesday, Jan. 26, I immediately experienced severe vertigo. After an hour of being unable to function normally, I took two meclizine tablets and slept for 12 hours. As of now (Friday night, Jan. 29). I have continued to experience vertigo--only mildly as I am sitting still or lying down, but severe vertigo (almost falling) if I move my head wrong.
fever; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiration date: not reported), via an unspecified route of administration, on 03Jun2021, as DOSE 2, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) DOSE 1, SINGLE  for covid-19 immunization (no reaction experienced).On 03Jun2021, the day patient received the 2nd shot of COVID vaccine, patient experienced fever. The outcome of event was unknown.  Additional information has been requested.